Abstract
Covalent inhibitors are emerging as a promising therapeutic means for efficient and sustained targeting of key disease-driving proteins. As for classic non-covalent inhibitors, understanding target engagement and selectivity is essential for determining optimal dosing and limiting potential on- or off-target toxicity. Here, we present a complementary activity-based protein profiling (ABPP) strategy for unbiased proteome-wide profiling of cysteine-reactive inhibitors based on two orthogonal approaches. We illustrate the use of clickable alkyne probes for in-gel fluorescence and mass spectrometry studies using a series of therapeutic XPO1 inhibitors as an example.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G et al (2014) Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov 13:419–431
Bunnage ME, Chekler EL, Jones LH (2013) Target validation using chemical probes. Nat Chem Biol 9:195–199
Stefaniak J, Huber KVM (2020) Importance of quantifying drug-target engagement in cells. ACS Med Chem Lett 11:403–406
Singh J, Petter RC, Baillie TA, Whitty A (2011) The resurgence of covalent drugs. Nat Rev Drug Discov 10:307–317
Rothweiler EM, Brennan PE, Huber KVM (2022) Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators. Biol Chem 403:391–402
Montano JL, Wang BJ, Volk RF, Warrington SE, Garda VG, Hofmann KL et al (2022) Improved electrophile design for exquisite covalent molecule selectivity. ACS Chem Biol
Jost C, Nitsche C, Scholz T, Roux L, Klein CD (2014) Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. J Med Chem 57:7590–7599
Vinogradova EV, Zhang X, Remillard D, Lazar DC, Suciu RM, Wang Y et al (2020) An activity-guided map of electrophile-cysteine interactions in primary human T cells. Cell 182:1009–26.e29
Robers MB, Friedman-Ohana R, Huber KVM, Kilpatrick L, Vasta JD, Berger BT et al (2020) Quantifying target occupancy of small molecules within living cells. Annu Rev Biochem 89:557–581
Ward JA, Pinto-Fernandez A, Cornelissen L, Bonham S, Diaz-Saez L, Riant O et al (2020) Re-evaluating the mechanism of action of alpha, beta-unsaturated carbonyl DUB Inhibitors b-AP15 and VLX1570: a paradigmatic example of unspecific protein cross-linking with Michael acceptor motif-containing drugs. J Med Chem 63:3756–3762
Ward JA, McLellan L, Stockley M, Gibson KR, Whitlock GA, Knights C et al (2016) Quantitative chemical proteomic profiling of ubiquitin specific proteases in intact cancer cells. ACS Chem Biol 11:3268–3272
Weerapana E, Speers AE, Cravatt BF (2007) Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)—a general method for mapping sites of probe modification in proteomes. Nat Protoc 2:1414–1425
Weerapana E, Wang C, Simon GM, Richter F, Khare S, Dillon MBD et al (2010) Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468:790–795
Zanon PRA, Yu F, Musacchio PZ, Lewald L, Zollo M, Krauskopf K et al (2021) Profiling the proteome-wide selectivity of diverse electrophiles. ChemRXiv
Hahm HS, Toroitich EK, Borne AL, Brulet JW, Libby AH, Yuan K et al (2019) Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol
Chung CY-S, Shin HR, Berdan CA, Ford B, Ward CC, Olzmann JA et al (2019) Covalent targeting of the vacuolar H+-ATPase activates autophagy via mTORC1 inhibition. Nat Chem Biol 15:776–785
Apel C, Kasper MA, Stieger CE, Hackenberger CPR, Christmann M (2019) Protein modification of lysine with 2-(2-Styrylcyclopropyl)ethanal. Org Lett 21:10043–10047
Ward CC, Kleinman JI, Nomura DK (2017) NHS-esters as versatile reactivity-based probes for mapping proteome-wide Ligandable hotspots. ACS Chem Biol 12:1478–1483
Lin S, Yang X, Jia S, Weeks AM, Hornsby M, Lee PS et al (2017) Redox-based reagents for chemoselective methionine bioconjugation. Science 355:597–602
Shannon DA, Gu C, McLaughlin CJ, Kaiser M, van der Hoorn RA, Weerapana E (2012) Sulfonyl fluoride analogues as activity-based probes for serine proteases. Chembiochem 13:2327–2330
Wang C, Abegg D, Dwyer BG, Adibekian A (2019) Discovery and evaluation of new activity-based probes for serine hydrolases. Chembiochem 20:2212–2216
Scheer S, Ackloo S, Medina TS, Schapira M, Li F, Ward JA et al (2019) A chemical biology toolbox to study protein methyltransferases and epigenetic signaling. Nat Commun 10:19
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rothweiler, E.M., Huber, K.V.M. (2023). Global Assessment of Drug Target Engagement and Selectivity of Covalent Cysteine-Reactive Inhibitors Using Alkyne-Functionalized Probes. In: Merk, D., Chaikuad, A. (eds) Chemogenomics. Methods in Molecular Biology, vol 2706. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3397-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3397-7_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3396-0
Online ISBN: 978-1-0716-3397-7
eBook Packages: Springer Protocols